TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
N4 Pharma ( (GB:N4P) ) has issued an update.
N4 Pharma announced its participation in the ShareSoc Growth Company Seminar, where CEO Nigel Theobald will discuss the development of Nuvec® for RNA therapeutics. The event will not disclose new material information, but a presentation link will be available on the company’s website, highlighting its ongoing efforts in gene delivery systems.
More about N4 Pharma
N4 Pharma plc is a UK-based biotechnology company focused on developing Nuvec®, a proprietary gene delivery system designed to facilitate advanced therapies for cancer and other diseases.
Average Trading Volume: 1,446,325
Technical Sentiment Signal: Hold
Current Market Cap: £8.76M
For an in-depth examination of N4P stock, go to TipRanks’ Overview page.